The short version of freeze-thaw fits in a sentence. The long version — which is the one that helps — is below.
Reviewed 2026-03-14. Anything still debated is marked as such rather than presented as settled.
Selank is a synthetic heptapeptide with the sequence Thr-Lys-Pro-Arg-Pro-Gly-Pro. It was designed at the Institute of Molecular Genetics of the Russian Academy of Sciences as a structural analogue of tuftsin, a naturally occurring tetrapeptide fragment of the immunoglobulin heavy chain. The added Pro-Gly-Pro tail was intended to slow enzymatic degradation and extend biological activity. In Russia it is registered as an anxiolytic nasal preparation, while regulators elsewhere have not approved it for clinical use.
Proposed mechanisms centre on modulation of the GABAergic system, with reports of altered expression of genes related to GABA-A receptor subunits and changed monoamine turnover. Some studies describe inhibition of enkephalinase, the enzyme that degrades endogenous enkephalins, which may prolong opioid peptide signalling. Effects on brain-derived neurotrophic factor and on cytokine expression have also been reported. These findings come largely from animal models and small human studies, and the precise primary target remains unresolved.
The compound has a calculated molecular weight near 751.9 daltons and carries a net positive charge at physiological pH because of its arginine residue. It dissolves freely in water and in common aqueous buffers, and typically appears as a white or off-white lyophilized powder. The amide backbone makes the molecule susceptible to peptidases, which limits oral use and favors intranasal or parenteral routes. Nomenclature in the literature varies: the substance is also described by the sequence abbreviation TP-7 and by a Russian trade designation.
Regulatory status differs sharply by region. Selank holds a Russian marketing authorization, where it is supplied mainly as nasal drops, while authorities elsewhere have not approved it for medical use. Material sold internationally is therefore usually labeled as a research chemical rather than a medicine. Peer-reviewed publications come predominantly from Russian laboratories, and sample sizes are generally small. Whether the compound produces comparable effects under independent, well-controlled replication remains an open question that the broader literature has not settled.
| Property | Value | Notes |
|---|---|---|
| Molecular formula | C33H57N11O9 | Free peptide form |
| Molecular mass | About 751.9 Da | Calculated average mass |
| Amino acid sequence | Thr-Lys-Pro-Arg-Pro-Gly-Pro | Single-letter form TKPRPGP |
| Structural basis | Tuftsin analogue | Extended version of a natural tetrapeptide |
| Development origin | Russian Academy of Sciences | Work carried out from the 1980s onward |
Selank is a synthetic heptapeptide developed in Russia. Its sequence is Thr-Lys-Pro-Arg-Pro-Gly-Pro, a seven-residue chain built around the natural tetrapeptide tuftsin. Researchers at the Institute of Molecular Genetics of the Russian Academy of Sciences first described the compound in the mid-1990s. The design combined the tuftsin core with an added Pro-Gly-Pro tail, a modification intended to extend the molecule's stability in biological fluids. Published work on the peptide has appeared mainly in Russian-language journals.
Reported activity for Selank centers on anxiolytic and nootropic effects. Russian clinical reports describe use in anxiety and in cognitive or attention-related complaints. Most of this evidence comes from studies conducted by the same research groups that developed the peptide. Independent replication in other countries remains limited, and no major Western regulatory agency has approved the compound for any indication. The gap between local reports and external verification is a recurring point in discussions of the peptide.
Tuftsin, the parent structure, is a naturally occurring immunomodulatory tetrapeptide released from the Fc region of immunoglobulin G by spleen enzymes. Selank extends this four-residue sequence with three additional amino acids. The stated rationale is that the added tail slows enzymatic breakdown and may influence receptor interactions. How the full heptapeptide behaves at the molecular level is not firmly established, and proposed mechanisms often involve indirect modulation of neurotransmitter or immune signaling rather than a single defined target.
Once dissolved, the peptide is markedly less stable than the dry powder. Aqueous solutions are subject to backbone hydrolysis and to microbial growth when they are handled without sterile technique. Buffered solutions near neutral pH are common for short-term laboratory work, while acidic conditions are sometimes used to improve solubility. Analytical laboratories generally prepare working solutions fresh rather than storing them, and a residual water film left in a reopened vial can seed degradation even when the container appears dry.
Reversed-phase high-performance liquid chromatography is the standard technique for estimating peptide purity. The result is a peak-area percentage, which describes how much of the detected material elutes as the main peak in one run. Mass spectrometry confirms the molecular mass and can reveal truncated, adducted, or otherwise modified species. Amino acid analysis or tandem mass spectrometry can address sequence fidelity when identity is in doubt. None of these measurements, taken alone, establishes that a sample is fit for any specific purpose.
Lyophilized selank is normally supplied as a dry powder and is considered stable for extended periods when kept cold and dry. Moisture uptake is the main practical threat, because absorbed water promotes both hydrolysis and aggregation in the solid state. Vials are usually warmed to room temperature before opening so that condensation does not form on the powder. Supplier documentation commonly specifies -20 °C for routine storage, with -80 °C used for material intended to be archived for years.
When injected secretly, it does not have any effect, whereas standard pain drugs have an effect, even if they are administered without the subject's awareness. The supposed mechanism is an enhancement of the neural pathways of expectation as a result of dopamine and endogenous opioids being suddenly released throughout numerous structures of the brain and spinal cord. The ventral tegmental area is the structure believed to mediate proglumide's analgesic and euphoric effects, however dozens of areas with a wide range of physical and psychological functions are implicated in the mediation of the placebo effect (this accounts for proglumide's ability to produce physically measurable effects on vital signs such as heart rate, blood pressure, respiration rate, and tidal volume which cannot be accounted for by its clinically insignificant δ-opioid affinity.
MASLD incidence is rapidly rising, along with obesity and diabetes, and has become the most common cause of liver disease in developed countries, for adults, teenagers, and children. The percentage of people with MASLD ranges from 9 to 36.9% in different parts of the world. Approximately 20% of the United States and 25% of the Asia-Pacific populations have non-alcoholic fatty liver. Similar prevalence can be found in Europe, although less data is available. MASLD is the most common in the Middle East (32%) and South America (30%), while Africa has the lowest rates (13%). Compared to the 2000s, NAFL and MASH respectively increased 2-fold and 2.5-fold in the 2010s in the USA. MASLD and MASH are more prevalent in Hispanics - which can be attributed to high rates of obesity and type 2 diabetes in Hispanic populations, intermediate in Whites, and lowest in Blacks. MASFLD was observed to be twice as prevalent in men as women. For severely obese individuals, the prevalence of MASLD rises over 90%, and for those with diabetes, over 60%, and up to 20% for normal-weight people. MASLD is present in 65% to 90% of people who have had bariatric surgery, and up to 75% of them have MASH. Ultrasonography and proton NMR spectroscopy studies suggest that about 25% of the population seems to be affected by MASLD or MASH. Although the disease is commonly associated with obesity, a significant proportion of those affected are of normal weight or lean.
Nevertheless, among different absorption-based techniques which are used for gaseous species detection, Cavity ring-down spectroscopy (CRDS) can be used as a calibration-free method. The fact that CRDS is based on the measurements of photon life-times (and not the laser intensity) makes it needless for any calibration and comparison with a reference Some instruments also automatically identify the substance being measured from a store of thousands of reference spectra held in storage.
Also that year, Schumer wrote a memoir, entitled The Girl with the Lower Back Tattoo. It held the top position on The New York Times Non-Fiction Best Seller list for two weeks in September 2016 and garnered her a nomination for the Grammy Award for Best Spoken Word Album. Schumer made her Broadway debut in 2017 acting in Steve Martin's comedy play Meteor Shower alongside Keegan-Michael Key, Laura Benanti and Jeremy Shamos. The play revolves around two couples in 1993 who spend an evening with each other. David Rooney of The Hollywood Reporter wrote "Schumer is one of four terrific performers who juice the entertainment of this high-sheen production...which would never have made it this far without Martin's name behind it, or more crucially, without the marquee draw of Schumer making her Broadway debut." Schumer was nominated for the Tony Award for Best Actress in a Play losing to Glenda Jackson for the revival of Edward Albee's Three Tall Women. In 2018, she starred in the comedy film I Feel Pretty which received negative reviews from critics. Spotify released the original podcast Amy Schumer Presents: 3 Girls, 1 Keith on June 21, 2018, starring Schumer and her best comedy friends Rachel Feinstein, Bridget Everett and Keith Robinson as they talk about comedy, pop culture, politics and their personal lives. She released her standup special Amy Schumer: Growing (2019) on Netflix to positive reviews. Schumer received a Primetime Emmy Award for Outstanding Writing for a Variety Special nomination.
Sources: en.wikipedia.org
Presumptive testing always precedes analysis of a questioned sample. Most presumptive tests involve a chemical reaction that results in a colour change that is detectable with the plain eye. Thorough documentation of the scene through notes, photographs etc. must be done prior to any presumptive or confirmatory testing in order to maintain chain of custody and avoid contamination. The Griess test and Walker test are two presumptive tests that can be used to determine if a questioned sample contains nitrites. The Walker test is used to determine GSR area on clothing using naphthylamine-sulfanilic acid soaked photograph paper. Red colouration appears when nitrite ions are present. A variant of the Griess test reagent is sulfanilamide and naphthylamine in an acidic medium. The Modified Griess test detects nitrite compounds, which are a by-product of the combustion of gunpowder. Forensic examiners use this test to determine the gun to target distance. This test is performed first because it does not interfere with the later sodium rhodizonate test. The presence of nitrite ions is what triggers the colour change, and therefore we do not consider this test to be indicative of GSR. The sodium rhodizonate test can detect the presence of lead and barium; it results in a red or purple color when lead is present in the tested area, and a reddish-brown colour when exposed to barium. It is an extremely sensitive, specific, and efficient method as it can obtain information on the origin of particulate debris, and it can be done on surfaces or objects.
Equine polysaccharide storage myopathy (EPSM, PSSM, EPSSM) is a hereditary glycogen storage disease of horses that causes exertional rhabdomyolysis. It is currently known to affect the following breeds: American Quarter Horses, American Paint Horses, Warmbloods, Cobs, Dales Ponies, Thoroughbreds, Arabians, New Forest ponies, and a large number of heavy horse breeds. While incurable, PSSM can be managed with appropriate diet and exercise. There are currently 2 subtypes, known as Type 1 PSSM and Type 2 PSSM.
1993/1483) A11 Trunk Road (Stump Cross to A505 Junction Improvement) Slip Roads Order 1993 (S.I. 1993/1484) M11 Motorway (Stump Cross Junction Improvement) and Connecting Roads Scheme 1993 (S.I. 1993/1485) A11 Trunk Road (Stump Cross to A505 Junction Improvement) (Detrunking) Order 1993 (S.I. 1993/1486) Firearms (Dangerous Air Weapons) (Amendment) Rules 1993 (S.I. 1993/1490) Education (Schools) Act 1992 (Commencement No. 3) Order 1993 (S.I. 1993/1491) Education (School Inspection) Regulations 1993 (S.I. 1993/1492) Non-Domestic Rating (Collection and Enforcement) (Local Lists) (Amendment) Regulations 1993 (S.I. 1993/1493) Non-Domestic Rating (Collection and Enforcement) (Central Lists) (Amendment) Regulations 1993 (S.I. 1993/1494) Non-Domestic Rating (Payment of Interest) (Amendment) Regulations 1993 (S.I. 1993/1495) Non-Domestic Rating Contributions (England) (Amendment) Regulations 1993 (S.I. 1993/1496)
Sources: en.wikipedia.org
It is a seven-amino-acid peptide, Thr-Lys-Pro-Arg-Pro-Gly-Pro, produced by chemical synthesis rather than extracted from biological tissue. Its design is based on tuftsin, a natural immunomodulatory tetrapeptide. The C-terminal Pro-Gly-Pro segment is a common stabilising motif in short regulatory peptides.
The core four residues correspond to tuftsin, which occurs naturally as part of immunoglobulin G. The full seven-residue sequence, however, is not a known endogenous peptide. It is a laboratory-designed analogue intended to combine tuftsin-like activity with greater resistance to breakdown.
No single receptor has been confirmed as the primary target. Reports describe involvement of the GABAergic system, interference with enkephalin degradation, and shifts in neurotrophic factor expression. Because these observations come from different models and assays, they have not yet been integrated into one accepted mechanism.
Selank is a synthetic seven-amino-acid peptide modeled on tuftsin, a fragment of the immunoglobulin G heavy chain. It was designed in Russia to combine anxiolytic and immunomodulatory properties in one molecule.